127 related articles for article (PubMed ID: 18042935)
1. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Ponti A; Rosso S; Zanetti R; Ricceri F; Tomatis M; Segnan N
J Natl Cancer Inst; 2007 Dec; 99(23):1817-8; author reply 1819. PubMed ID: 18042935
[No Abstract] [Full Text] [Related]
2. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Anderson BO
J Natl Cancer Inst; 2007 Dec; 99(23):1815-6; author reply 1816-7. PubMed ID: 18042937
[No Abstract] [Full Text] [Related]
3. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
4. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Chu DZ
J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
[No Abstract] [Full Text] [Related]
5. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Robbins AS; Clarke CA
J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938
[No Abstract] [Full Text] [Related]
6. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Byers T; Trujillo S; Hines L
J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
[No Abstract] [Full Text] [Related]
7. Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.
Suhrke P; Mæhlen J; Zahl PH
Breast J; 2012; 18(6):549-56. PubMed ID: 23002918
[TBL] [Abstract][Full Text] [Related]
8. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L
J Natl Cancer Inst; 2008 Apr; 100(8):597-8; author reply 599. PubMed ID: 18398101
[No Abstract] [Full Text] [Related]
9. In situ breast cancer: incidence trend and organised screening programmes in Italy.
Barchielli A; Federico M; De Lisi V; Bucchi L; Ferretti S; Paci E; Ponti A; Buiatti E
Eur J Cancer; 2005 May; 41(7):1045-50. PubMed ID: 15862754
[TBL] [Abstract][Full Text] [Related]
10. [Breast cancer screening in the elderly].
Amodeo C; Caglià P; Gandolfo L; Veroux M; Brancato G; Immè A
Tumori; 2003; 89(4 Suppl):173-4. PubMed ID: 12903582
[TBL] [Abstract][Full Text] [Related]
11. Screening and detection of breast cancer and prostate cancer.
Saloustros E; Mavroudis D
JAMA; 2010 Mar; 303(11):1032; author reply 1033-4. PubMed ID: 20233817
[No Abstract] [Full Text] [Related]
12. Overdiagnosis of breast cancer after 14 years of mammography screening.
Zahl PH; Mæhlen J
Tidsskr Nor Laegeforen; 2012 Feb; 132(4):414-7. PubMed ID: 22353833
[TBL] [Abstract][Full Text] [Related]
13. Population-based mammography screening and breast cancer incidence in New South Wales, Australia.
Chiu C; Morrell S; Page A; Rickard M; Brassil A; Taylor R
Cancer Causes Control; 2006 Mar; 17(2):153-60. PubMed ID: 16425093
[TBL] [Abstract][Full Text] [Related]
14. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
[No Abstract] [Full Text] [Related]
15. Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.
Farhat GN; Walker R; Buist DS; Onega T; Kerlikowske K
J Clin Oncol; 2010 Dec; 28(35):5140-6. PubMed ID: 21060026
[TBL] [Abstract][Full Text] [Related]
16. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
17. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
18. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Vaidya JS
J Natl Cancer Inst; 2008 Apr; 100(8):598-9; author reply 599. PubMed ID: 18398100
[No Abstract] [Full Text] [Related]
19. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
20. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
